Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor.
about
Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloidesLarge FK506-Binding Proteins Shape the Pharmacology of RapamycinA functional variomics tool for discovering drug-resistance genes and drug targets.Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatusThe Potential of Streptomyces as Biocontrol Agents against the Rice Blast Fungus, Magnaporthe oryzae (Pyricularia oryzae)A non-canonical RNA degradation pathway suppresses RNAi-dependent epimutations in the human fungal pathogen Mucor circinelloides.Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosisStructures of Pathogenic Fungal FKBP12s Reveal Possible Self-Catalysis Function.Blunted dynamics of adenosine A2A receptors is associated with increased susceptibility to Candida albicans infection in the elderly.An overview of rapamycin: from discovery to future perspectives.Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.Antifungal drug resistance evoked via RNAi-dependent epimutations.FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in MalasseziaMethodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.The Use of Larvae to Identify Novel Antimicrobial Agents against Fungal Species of Medical InterestStandardization of Larvae to Provide Reliable and Reproducible Results in the Study of Fungal PathogensBiguanides enhance antifungal activity against Candida glabrata
P2860
Q27333075-E04A3945-7A32-489B-A502-C80851078BECQ27676039-1F4EBF1F-888A-4992-B00B-4C54B5127C4CQ27932829-0154D1FF-26A5-4016-9B7C-A21BC1AC9CBAQ28547946-4CA327BC-D2FD-4851-8C68-FB218C6B32F7Q28817135-D976FB65-7598-43A9-A93A-FE3CB1A91584Q36322038-6E012AF9-8E2F-4556-B3E2-10ADA04F07AEQ36584655-4C407280-FCEC-47AC-9AE6-E7FE514DF837Q36849948-77D8AFE1-7C04-4602-B0FA-CE3E7B53E194Q37665179-AAC208BF-D853-48D5-9D5C-848038DC08A0Q38822715-8047F973-9417-43F9-A652-B6D22918E86AQ38871002-E4650EA2-37A4-45DF-BD71-2AC0FA222B66Q41852042-5D49667E-3D86-495D-8D90-D8B05E578780Q42638827-B729BC7E-A901-4897-AF3D-6D60FB2970D9Q55511181-5837E622-245C-4837-8A5B-B9B832F51FA8Q58716618-95A9A877-F373-464A-BFC8-A47E4D240896Q58761035-1E6EB788-C87B-401B-ADFE-B2AB07CF8F48Q58806129-B9E58E8E-71C9-4F4A-ADE9-11D5967BC74D
P2860
Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rapamycin exerts antifungal ac ...... 2-dependent inhibition of Tor.
@en
type
label
Rapamycin exerts antifungal ac ...... 2-dependent inhibition of Tor.
@en
prefLabel
Rapamycin exerts antifungal ac ...... 2-dependent inhibition of Tor.
@en
P2093
P2860
P356
P1433
P1476
Rapamycin exerts antifungal ac ...... 2-dependent inhibition of Tor.
@en
P2093
Cecelia A Shertz
Maria E Cardenas
Robert J Bastidas
Soo Chan Lee
P2860
P304
P356
10.1128/EC.05284-11
P577
2011-12-30T00:00:00Z